Research programme: small molecules antimalaria therapeutics - Elkurt/Rhode Island Hospital
Latest Information Update: 06 Sep 2023
At a glance
- Originator Rhode Island Hospital
- Developer Ocean Biomedical
- Class Antiparasitics; Small molecules
- Mechanism of Action Plasmodium falciparum GARP protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Malaria